2023The Egyptian Journal of Internal MedicineOpen access

Serotonin syndrome: a rare undiagnosed cause of hyperpyrexia

Hamdy Ibrahim, Safwat Abdel Maksod, Magdy Khorshed, Hanan Rady, Ahmed Alsisi, Adel Mohamed, Omar Alkassas, Marwa Haron, Suzan Saied

Open full text 1 citations

Abstract

Abstract Serotonin syndrome (SS) is a rare but potentially life-threatening condition, and it is caused by increasing serotonergic activities. It is an underdiagnosed and under-reported condition. Clinical manifestations can range from mild to moderate to severe symptoms. The intensity of symptoms reflects the degree of serotonin toxicity, and mild serotonin syndrome is easily overlooked by physicians. Severe serotonin toxicity typically occurs to a combination of serotonergic agents. Herein, we describe a case of severe serotonin toxicity in a 38-year-old Egyptian male with a history of generalized anxiety disorder and depression. With increased depressive symptoms, he received 20 mg of fluoxetine daily, and the symptoms developed 1 month after starting fluoxetine, which is the uncommon onset of presentation. The patient was already on tramadol for chronic low backache. The aim is to increase awareness of the syndrome among physicians and neuropsychiatrists.

Open-access reader

About this research paper

What this paper is about

Abstract Serotonin syndrome (SS) is a rare but potentially life-threatening condition, and it is caused by increasing serotonergic activities. It is an underdiagnosed and under-reported condition. Clinical manifestations can range from mild to moderate to severe symptoms. The intensity of symptoms reflects the degree of serotonin toxicity, and mild serotonin syndrome is easily overlooked by physicians. Severe serotonin toxicity typically occurs to a combination of serotonergic agents. Herein, we describe a case of severe serotonin toxicity in a 38-year-old Egyptian male with a history of generalized anxiety disorder and depression. With increased depressive symptoms, he received 20 mg of fluoxetine daily, and the symptoms developed 1 month after starting fluoxetine, which is the uncommon onset of presentation. The patient was already on tramadol for chronic low backache. The aim is to increase awareness of the syndrome among physicians and neuropsychiatrists.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract Serotonin syndrome (SS) is a rare but potentially life-threatening condition, and it is caused by increasing serotonergic activities. It is an underdiagnosed and under-reported condition. Clinical manifestations can range from mild to moderate to severe symptoms. The intensity of symptoms reflects the degree of serotonin toxicity, and mild serotonin syndrome is easily overlooked by physicians. Severe serotonin toxicity typically occurs to a combination of serotonergic agents. Herein, we describe a case of severe serotonin toxicity in a 38-year-old Egyptian male with a history of generalized anxiety disorder and depression. With increased depressive symptoms, he received 20 mg of fluoxetine daily, and the symptoms developed 1 month after starting fluoxetine, which is the uncommon onset of presentation. The patient was already on tramadol for chronic low backache. The aim is to increase awareness of the syndrome among physicians and neuropsychiatrists.

Key concepts: Serotonin syndrome, Serotonergic, Fluoxetine, Serotonin, Medicine, Depression (economics), Tramadol, Toxicity

Related papers

Back to paper searchBrowse research topicsOriginal source
Serotonin syndrome: a rare undiagnosed cause of hyperpyrexia — Research Paper | ScholarLens